183 related articles for article (PubMed ID: 16856817)
1. Protein C, protein S, and thrombomodulin in amniotic fluid. A preliminary study.
Uszyński M; Zekanowska E; Kotzbach M; Uszyński W; Kotzbach R
J Perinat Med; 2006; 34(4):289-92. PubMed ID: 16856817
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of the protein C system in mother's blood, cord blood and amniotic fluid.
Uszyński M; Uszyński W; Zekanowska E; Kuczyński J; Szymański M
Folia Histochem Cytobiol; 2010 Jan; 48(2):262-6. PubMed ID: 20675283
[TBL] [Abstract][Full Text] [Related]
3. Thrombin activatable fibrinolysis inhibitor (TAFI) in human amniotic fluid. A preliminary study.
Uszyński W; Uszyński M; Zekanowska E
Thromb Res; 2007; 119(2):241-5. PubMed ID: 16540154
[TBL] [Abstract][Full Text] [Related]
4. Thrombomodulin in human gestational tissues: placenta, fetal membranes and myometrium.
Uszyński M; Sztenc S; Zekanowska E; Uszyński W
Adv Med Sci; 2006; 51():312-5. PubMed ID: 17357332
[TBL] [Abstract][Full Text] [Related]
5. [Protein C system in patients with idiopathic pulmonary fibrosis--preliminary report].
Kiziewicz A; Zekanowska E; Cieśliński K; Góralczyk K
Pneumonol Alergol Pol; 2008; 76(4):225-8. PubMed ID: 18785126
[TBL] [Abstract][Full Text] [Related]
6. Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6.
Undar L; Ertuğrul C; Altunbaş H; Akça S
Thromb Haemost; 1999 Apr; 81(4):571-5. PubMed ID: 10235441
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
Strandberg K; Svensson PJ; Ohlin AK
Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
[TBL] [Abstract][Full Text] [Related]
8. Expression of protein C (PC), protein S (PS) and thrombomodulin (TM) in human colorectal cancer.
Sierko E; Wojtukiewicz MZ; Zawadzki R; Zimnoch L; Kisiel W
Thromb Res; 2010 Mar; 125(3):e71-5. PubMed ID: 19818470
[TBL] [Abstract][Full Text] [Related]
9. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
10. Activation contact system (ACS) and tissue factor (TF) in human amniotic fluid: measurements of ACS components and TF, and some implications on the pathophysiology of amniotic fluid embolism.
Uszyński W; Żekanowska E; Uszyński M; Kieszkowski P
Thromb Res; 2015 Apr; 135(4):699-702. PubMed ID: 25669600
[TBL] [Abstract][Full Text] [Related]
11. [A novel assay for detecting the thrombomodulin-protein C/S anticoagulant pathway using human thrombomodulin (prothrombinase assay)].
Mohri M; Sata M; Gomi K; Maruyama Y; Osame M; Maruyama I
Rinsho Byori; 1997 Feb; Suppl 104():203-4. PubMed ID: 9128383
[No Abstract] [Full Text] [Related]
12. Effects of activated protein C on coagulation and fibrinolysis in rabbits with endotoxin induced acute lung injury.
He HY; Wang C; Pang BS
Chin Med J (Engl); 2008 Dec; 121(24):2561-5. PubMed ID: 19187596
[TBL] [Abstract][Full Text] [Related]
13. Changes in regulating blood coagulation in hepatic resection with special references to soluble thrombomodulin and protein C.
Shimada M; Matsumata T; Kamakura T; Suehiro T; Itasaka H; Sugimachi K
J Am Coll Surg; 1994 Jan; 178(1):65-8. PubMed ID: 8156121
[TBL] [Abstract][Full Text] [Related]
14. Galanin concentrations in maternal circulation, amniotic fluid and umbilical cord blood during term labor: relationship with maternal body mass and neonatal birth weight.
Zamłyński J; Chudek J; Olejek A; Kobylec-Zamłyńska B; Mańka G; Bodzek P; Wiecek A
Gynecol Endocrinol; 2007 May; 23(5):295-9. PubMed ID: 17558689
[TBL] [Abstract][Full Text] [Related]
15. Procoagulant activity and phosphatidylserine of amniotic fluid cells.
Zhou J; Liu S; Ma M; Hou J; Yu H; Lu C; Gilbert GE; Shi J
Thromb Haemost; 2009 May; 101(5):845-51. PubMed ID: 19404537
[TBL] [Abstract][Full Text] [Related]
16. Effect of amniotic fluid on coagulation and platelet function in pregnancy: an evaluation using thromboelastography.
Harnett MJ; Hepner DL; Datta S; Kodali BS
Anaesthesia; 2005 Nov; 60(11):1068-72. PubMed ID: 16229690
[TBL] [Abstract][Full Text] [Related]
17. [Progression from a routine examination to a study. Having come this far, what should be done from now? A thrombosis risk factor study].
Suehisa E
Rinsho Byori; 2008 Oct; 56(10):924-9. PubMed ID: 19068790
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between amniotic fluid glucose concentration and amniotic fluid volume and neonatal birth weight in pregnancy complicated by gestational diabetes mellitus].
Xu ZM; Wu LF
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):724-8. PubMed ID: 17327026
[TBL] [Abstract][Full Text] [Related]
19. The protein C omega-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activity.
Preston RJ; Morse C; Murden SL; Brady SK; O'Donnell JS; Mumford AD
Br J Haematol; 2009 Mar; 144(6):946-53. PubMed ID: 19133979
[TBL] [Abstract][Full Text] [Related]
20. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome.
Oral B; Mermi B; Dilek M; Alanoğlu G; Sütçü R
Gynecol Endocrinol; 2009 Feb; 25(2):110-6. PubMed ID: 19253106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
